Open-label randomized control trial of hydroxychloroquine in patients with moderate to severe coronavirus disease 2019 infection

BACKGROUND: At onset of coronavirus disease 2019 (COVID-19) pandemic, hydroxychloroquine (HCQ) was repurposed for treatment of patients based on reports that it had in vitro activity. The aim of this study was to find out if HCQ reduces number of days of hospitalization when given to patients with m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Med J Armed Forces India
Main Authors: Gupta, Salil, Dixit, Prashant Kumar, Ghana, Parthasarathi, Abhisheka, Kumar, Khurana, Harshit, Jha, Vijoy Kumar, Mahapatra, Debasish, Goel, Jitesh, Ahmed, Safia, Varadaraj, G.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8313076/
https://ncbi.nlm.nih.gov/pubmed/34334898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mjafi.2021.02.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados